Cargando…

Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication

INTRODUCTION: To examine the association of sleep duration, insomnia, and obstructive sleep apnea (OSA) with hemoglobin A1c (HbA1c) in a cohort of patients with type 2 diabetes (T2D) on glucose-lowering medications. RESEARCH DESIGN AND METHODS: 13 346 patients with T2D were included in the present a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Xiao, Benedict, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Epidemiology/Health services research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462247/ https://www.ncbi.nlm.nih.gov/pubmed/32868313 http://dx.doi.org/10.1136/bmjdrc-2020-001702

Ejemplares similares

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients
por: Zhao, Wenhui, et al.
Publicado: (2014)

Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study
por: Skriver, Mette V, et al.
Publicado: (2015)

HbA(1c) as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial
Publicado: (2015)

Undiagnosed diabetes based on HbA(1c) by socioeconomic status and healthcare consumption in the Tromsø Study 1994–2016
por: Ruiz, Paz Lopez-Doriga, et al.
Publicado: (2021)

Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
por: Edqvist, Jon, et al.
Publicado: (2021)

The Impact of Carbamylation and Anemia on HbA(1c)’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease
por: Tang, Mengyao, et al.
Publicado: (2023)

Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USA
por: Pagán, Lorissa, et al.
Publicado: (2023)

Derivation and external validation of a clinical version of the German Diabetes Risk Score (GDRS) including measures of HbA1c
por: Mühlenbruch, Kristin, et al.
Publicado: (2018)

Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study
por: Barron, Emma, et al.
Publicado: (2020)

Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark
por: Nicolaisen, Sia K, et al.
Publicado: (2022)

Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014)

Effect of the interaction between physical activity and estimated macronutrient intake on HbA1c: population-based cross-sectional and longitudinal studies
por: Furukawa, Takuma, et al.
Publicado: (2022)

New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
por: Lu, Yunxia, et al.
Publicado: (2015)

Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional study
por: Hodel, Nikolai Carl, et al.
Publicado: (2020)

Glycated hemoglobin (HbA1c) as diagnostic criteria for diabetes: the optimal cut-off points values for the Pakistani population; a study from second National Diabetes Survey of Pakistan (NDSP) 2016–2017
por: Basit, Abdul, et al.
Publicado: (2020)

Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands
por: van den Heuvel, Jan Maurik, et al.
Publicado: (2020)

Type 2 diabetes medication and HbA1c levels in North Karelia Finland, 2013–2019
por: Wikström, Katja, et al.
Publicado: (2022)

Associations between adolescent experiences, parent experiences and HbA1c: results following two surveys based on the Norwegian Childhood Diabetes Registry (NCDR)
por: Iversen, Hilde Hestad, et al.
Publicado: (2019)

Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19
por: Wander, Pandora L., et al.
Publicado: (2021)

Assessing widening disparities in HbA1c and systolic blood pressure retesting during the COVID-19 pandemic in an LGBTQ+-focused federally qualified health center in Chicago: a retrospective cohort study using electronic health records
por: Rivera, Adovich S, et al.
Publicado: (2022)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
por: Bongaerts, Brenda, et al.
Publicado: (2021)

Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT
por: Varvel, Stephen A, et al.
Publicado: (2014)

Using point-of-care HbA1c to facilitate the identification of diabetes and abnormal glucose regulation in primary healthcare settings
por: Pi, Linhua, et al.
Publicado: (2023)

IDF2022-0948 Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a ‘Nearly Post COVID-19’ World
por: Fryer, A., et al.
Publicado: (2023)

Sleep Disturbances and Glucose Metabolism in Older Adults: The Cardiovascular Health Study
por: Strand, Linn Beate, et al.
Publicado: (2015)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Postprandial glucose and HbA1c are associated with severity of obstructive sleep apnoea in non-diabetic obese subjects
por: Cignarelli, A., et al.
Publicado: (2021)

Artifactually lowered glycosylated hemoglobin (HbA1c %) in patient with diabetes on dapsone
por: Rastogi, Amit, et al.
Publicado: (2012)

Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
por: Jeon, Ja Young, et al.
Publicado: (2013)

Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromsø Study 1994–2016
por: Langholz, Petja Lyn, et al.
Publicado: (2021)

Hemoglobin A1c in combination with fasting plasma glucose trumps fasting plasma glucose alone as predictive indicators for diabetes mellitus: an ambidirectional cohort study of Thai people with impaired fasting glucose
por: Thamakaison, Sangsulee, et al.
Publicado: (2021)

Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
por: Inoue, Kosuke, et al.
Publicado: (2021)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients
por: Sia, Ching-Hui, et al.
Publicado: (2021)

Bimodal Distribution of Glucose Is Not Universally Useful for Diagnosing Diabetes
por: Vistisen, Dorte, et al.
Publicado: (2009)

Lower vitamin D levels are associated with higher blood glucose levels in Asian Indian women with pre-diabetes: a population-based cross-sectional study in North India
por: Bhatt, Surya Prakash, et al.
Publicado: (2018)

Initiating SGLT2 inhibitor therapy to improve renal outcomes for persons with diabetes eligible for an intensified glucose-lowering regimen: hypothetical intervention using parametric g-formula modeling
por: Takeuchi, Masato, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u9id58s2fl8l0dif7l2bb74up4